• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

DESLORATADINE Drug Record

  • Summary
  • Interactions
  • Claims
  • DESLORATADINE chembl:CHEMBL1172 Approved

    Alternate Names:

    CLARINEX
    DESLORATADINE
    LORATADINE RELATED COMPOUND A
    MIDETORIN
    NEOCLARITYN
    SCH-34117
    AERIUS
    LORATADINE RELATED COMPOUND A RS
    8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDINYLIDENE)-5H-BENZO(5,6)CYCLOHEPTA(1,2-B)PYRIDINE
    DESCARBOETHOXYLORATADINE
    CLARINEX®
    8-CHLORO-11-PIPERIDIN-4-YLIDENE-6,11-DIHYDRO-5H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE
    8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDINYLIDENE)-5H-BENZO(5,6)CYCLOHEPTA(1,2-B)LDGACDN
    rxcui:275635
    chemidplus:100643-71-8
    chembl:CHEMBL1172
    pubchem.compound:124087
    drugbank:00967

    Drug Info:

    FDA Approval approved
    Drug Class Small Molecule
    Drug Indications antiallergy agent
    Year of Approval 2001
    Drug Class anti-allergic agents
    (3 More Sources)

    Publications:

    Li J et al., 2020, Human H1 receptor (HRH1) gene polymorphism is associated with the severity of side effects after desloratadine treatment in Chinese patients with chronic spontaneous uticaria., Pharmacogenomics J
    Simons et al., 2003, Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis., J. Allergy Clin. Immunol.
    Cieślewicz et al., 1995, [Effect of loratadine, selective antagonist of histamine H1 receptors, on histamine-induced bronchoconstriction]., Pneumonol Alergol Pol
    Devillier et al., 2008, Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review., Clin Pharmacokinet
    Letari et al., 1994, Effects of loratadine on cytosolic Ca2+ levels and leukotriene release: novel mechanisms of action independent of the anti-histamine activity., Eur. J. Pharmacol.
    Wu et al., 2004, Desloratadine inhibits constitutive and histamine-stimulated nuclear factor-kappaB activity consistent with inverse agonism at the histamine H1 Receptor., Int. Arch. Allergy Immunol.
    Dhanya et al., Comparative efficacy of levocetirizine, desloratidine and fexofenadine by histamine wheal suppression test., Indian J Dermatol Venereol Leprol
    Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
    DuBuske, 2007, Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy., Am J Clin Dermatol
    Rendic S et al., 1997, Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors., Drug Metab Rev
    Guo A et al., 2015, Association of FCER1A genetic polymorphisms with risk for chronic spontaneous urticaria and efficacy of nonsedating H1-antihistamines in Chinese patients., Arch Dermatol Res
  • DESLORATADINE   FCER1A

    Interaction Score: 10.3

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    25412950


    Sources:
    PharmGKB

  • DESLORATADINE   HRH1

    Interaction Score: 1.73

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Mechanism of Interaction Histamine H1 receptor antagonist
    Direct Interaction yes
    Trial Name desloratadine , Clarinex

    PMIDs:
    31406237 12642846 7581058 18336052 8174605 15564772 18797058 11752352 17902729


    Sources:
    TdgClinicalTrial ChemblInteractions TEND PharmGKB TTD

  • DESLORATADINE   PPARD

    Interaction Score: 0.12

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • DESLORATADINE   CYP3A4

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    9187528


    Sources:
    PharmGKB

  • TEND: DESLORATADINE

    • Version: 01-August-2011

    Alternate Names:
    DESLORATADINE Primary Drug Name

    Drug Info:
    Drug Class anti-allergic agents
    Year of Approval 2001

    Publications:

  • TdgClinicalTrial: DESLORATADINE

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antiallergy agent
    Drug Class Small Molecule
    FDA Approval approved

    Publications:

  • PharmGKB: desloratadine

    • Version: 18-August-2020

    Alternate Names:

    Drug Info:

    Publications:
    Rendic S et al., 1997, Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors., Drug Metab Rev
    Guo A et al., 2015, Association of FCER1A genetic polymorphisms with risk for chronic spontaneous urticaria and efficacy of nonsedating H1-antihistamines in Chinese patients., Arch Dermatol Res
    Li J et al., 2020, Human H1 receptor (HRH1) gene polymorphism is associated with the severity of side effects after desloratadine treatment in Chinese patients with chronic spontaneous uticaria., Pharmacogenomics J

  • DTC: DESLORATADINE

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL1172 ChEMBL Drug ID

    Drug Info:

    Publications:

  • TTD: Desloratadine

    • Version: 2020.06.01

    Alternate Names:
    D01GBY TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL1172

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

  • ChemblInteractions: CHEMBL1172

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21